Posted on March 21, 20253/21/25
Overcoming the Odds: How EVERSANA Helped a Family Navigate Their Rare Disease Journey
Posted on September 27, 20249/27/24
Behind the Breakthroughs and Practice-Changing Advances: Insights from ESMO 2024
Posted on July 8, 20247/8/24
Report: Integrated Delivery Network Trends and Engagement Strategies Every Drug Manufacturer Needs to Know
Posted on May 23, 20245/23/24
Integrated Delivery Networks (IDNs): Driving Change in Drug Access and Utilization
Posted on November 15, 202311/15/23
Incorporating Medical Science Liaisons Early and Often Amplifies Impact and Delivers Stronger Patient Outcomes
Posted on September 19, 20239/19/23
New Models of Benefits Verification Solve for Complexity, Accelerate Speed to Therapy and Deliver Price Transparency
Posted on June 16, 20236/16/23
Digital Guide to Commercializing Complex Therapeutics
Posted on August 19, 20228/19/22
Case Study: Leveraging Machine Learning Models in Patient Identification and Behavior Prediction for Rare Disease Indications
Posted on June 1, 20226/1/22
New Medicines, New Access, New Frontiers
Posted on April 20, 20224/20/22